Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Challenge of Evaluating Adnexal Masses in Patients With Breast Cancer.
Reinert T, Nogueira-Rodrigues A, Kestelman FP, Ashton-Prolla P, Graudenz MS, Bines J. Reinert T, et al. Among authors: graudenz ms. Clin Breast Cancer. 2018 Aug;18(4):e587-e594. doi: 10.1016/j.clbc.2018.03.006. Epub 2018 Mar 12. Clin Breast Cancer. 2018. PMID: 29680194 Review.
A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).
Caleffi M, Ribeiro RA, Duarte Filho DL, Ashton-Prolla P, Bedin AJ Jr, Skonieski GP, Zignani JM, Giacomazzi J, Franco LR, Graudenz M, Pohlmann P, Fernandes JG, Kivitz P, Weber B. Caleffi M, et al. BMC Public Health. 2009 Mar 13;9:83. doi: 10.1186/1471-2458-9-83. BMC Public Health. 2009. PMID: 19284670 Free PMC article.
A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.
Giacomazzi J, Koehler-Santos P, Palmero EI, Graudenz MS, Rivero LF, Lima E, Pütten AC, Hainaut P, Camey SA, Michelli RD, Neto CS, Fitarelli-Kiehl M, Geyer G, Meurer L, Geiger A, Azevedo MB, da Silva VD, Ashton-Prolla P. Giacomazzi J, et al. Among authors: graudenz ms. Virchows Arch. 2013 Jul;463(1):17-22. doi: 10.1007/s00428-013-1439-8. Epub 2013 Jun 21. Virchows Arch. 2013. PMID: 23794094
Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
Giacomazzi J, Graudenz MS, Osorio CA, Koehler-Santos P, Palmero EI, Zagonel-Oliveira M, Michelli RA, Scapulatempo Neto C, Fernandes GC, Achatz MI, Martel-Planche G, Soares FA, Caleffi M, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P. Giacomazzi J, et al. Among authors: graudenz ms. PLoS One. 2014 Jun 17;9(6):e99893. doi: 10.1371/journal.pone.0099893. eCollection 2014. PLoS One. 2014. PMID: 24936644 Free PMC article.
The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers.
Fitarelli-Kiehl M, Giacomazzi J, Santos-Silva P, Graudenz MS, Palmero EI, Michelli RA, Achatz MI, de Toledo Osório CA, de Faria Ferraz VE, Picanço CG, Ashton-Prolla P. Fitarelli-Kiehl M, et al. Among authors: graudenz ms. Fam Cancer. 2015 Jun;14(2):333-6. doi: 10.1007/s10689-015-9779-y. Fam Cancer. 2015. PMID: 25564201
ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy.
Reinert T, Ramalho S, de Vasconcelos VCA, Silva LR, da Silva AER, de Andrade CA, Kraft MBPL, Coelho GP, Mandelli J, Binotto M, Cabello C, de Paiva Silva GR, Bines J, Barrios CH, Ellis MJ, Graudenz MS. Reinert T, et al. Among authors: graudenz ms. Front Oncol. 2020 Apr 3;10:342. doi: 10.3389/fonc.2020.00342. eCollection 2020. Front Oncol. 2020. PMID: 32309212 Free PMC article.
37 results